Synidrytis financials
A multi-period view of the public annual-account figures reported for Synidrytis, with comparable measures and links to available source documents.
Company overviewRegistry number
0768580686
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for Synidrytis
2025 versus 2024
- Operating line
- €8,781
- EBITDA
- €8,237
- Total assets
- €25,341
- Equity
- €15,642
-16.1%
-17.1%
+37.3%
+41.5%
EBITDA margin +93.8% · Equity ratio +61.7%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €8,781 | €8,237 | €25,341 | €15,642 | - |
| 202431 Dec 2024 | €10,468 | €9,940 | €18,459 | €11,056 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.